Mitesco (OTCMKTS:MITI) & 111 (NASDAQ:YI) Financial Analysis

111 (NASDAQ:YI) and Mitesco (OTCMKTS:MITI) are both small-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their dividends, analyst recommendations, profitability, earnings, risk, institutional ownership and valuation.

Institutional & Insider Ownership

21.3% of 111 shares are held by institutional investors. Comparatively, 0.0% of Mitesco shares are held by institutional investors. 43.9% of 111 shares are held by insiders. Comparatively, 4.9% of Mitesco shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Analyst Ratings

This is a summary of recent ratings and recommmendations for 111 and Mitesco, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
111	1	0	0	0	1.00
Mitesco	0	0	0	0	0.00

Profitability

This table compares 111 and Mitesco’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
111	-0.52%	N/A	-2.70%
Mitesco	-7,638.20%	N/A	-2,270.77%

Valuation and Earnings

This table compares 111 and Mitesco”s revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
111	$1.97 billion	0.02	-$1.42 million	($0.84)	-5.96
Mitesco	$40,000.00	29.01	-$2.51 million	($0.14)	-0.48

111 has higher revenue and earnings than Mitesco. 111 is trading at a lower price-to-earnings ratio than Mitesco, indicating that it is currently the more affordable of the two stocks.

Volatility & Risk

111 has a beta of 0.51, suggesting that its share price is 49% less volatile than the S&P 500. Comparatively, Mitesco has a beta of 2.58, suggesting that its share price is 158% more volatile than the S&P 500.

Summary

111 beats Mitesco on 7 of the 11 factors compared between the two stocks.

About 111

111, Inc. engages in the provision of pharmaceutical products and medical services through online retail pharmacy and indirectly through offline pharmacy network. It operates through the B2C and B2B segments. The B2C segment engages in the sale of pharmaceutical and other health and wellness products directly to consumers through 1 Drugstore and its offline pharmacies. The B2B segment includes the sale of pharmaceutical products to pharmacy customers through 1 Drug Mall. The company was founded by Gang Yu and Jun Ling Liu in May 2013 and is headquartered in Shanghai, China.

About Mitesco

Mitesco, Inc. does not have significant operations. Previously, it was engaged in healthcare technology and services business. Mitesco, Inc. is based in Vero Beach, Florida.